513 related articles for article (PubMed ID: 14634763)
1. [A xenogeneic acellularized matrix for heart valve tissue engineering: in vivo study in a sheep model].
Leyh R; Wilhelmi M; Haverich A; Mertsching H
Z Kardiol; 2003 Nov; 92(11):938-46. PubMed ID: 14634763
[TBL] [Abstract][Full Text] [Related]
2. Tissue engineering of viable pulmonary arteries for surgical correction of congenital heart defects.
Leyh RG; Wilhelmi M; Rebe P; Ciboutari S; Haverich A; Mertsching H
Ann Thorac Surg; 2006 Apr; 81(4):1466-70; discussion 1470-1. PubMed ID: 16564294
[TBL] [Abstract][Full Text] [Related]
3. Tissue-engineered heart valves. Autologous valve leaflet replacement study in a lamb model.
Shinoka T; Ma PX; Shum-Tim D; Breuer CK; Cusick RA; Zund G; Langer R; Vacanti JP; Mayer JE
Circulation; 1996 Nov; 94(9 Suppl):II164-8. PubMed ID: 8901739
[TBL] [Abstract][Full Text] [Related]
4. In vivo repopulation of xenogeneic and allogeneic acellular valve matrix conduits in the pulmonary circulation.
Leyh RG; Wilhelmi M; Rebe P; Fischer S; Kofidis T; Haverich A; Mertsching H
Ann Thorac Surg; 2003 May; 75(5):1457-63; discussion 1463. PubMed ID: 12735562
[TBL] [Abstract][Full Text] [Related]
5. [Preparation of acellularized porcine heart valve and seeding of bovine aortic endothelial cells].
Ye FL; Xu ZY; Zhang BR
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2003 Nov; 17(6):493-5. PubMed ID: 14663951
[TBL] [Abstract][Full Text] [Related]
6. Prototype anionic detergent technique used to decellularize allograft valve conduits evaluated in the right ventricular outflow tract in sheep.
Hilbert SL; Yanagida R; Souza J; Wolfinbarger L; Jones AL; Krueger P; Stearns G; Bert A; Hopkins RA
J Heart Valve Dis; 2004 Sep; 13(5):831-40. PubMed ID: 15473487
[TBL] [Abstract][Full Text] [Related]
7. In vivo autologous recellularization of a tissue-engineered heart valve: are bone marrow mesenchymal stem cells the best candidates?
Vincentelli A; Wautot F; Juthier F; Fouquet O; Corseaux D; Marechaux S; Le Tourneau T; Fabre O; Susen S; Van Belle E; Mouquet F; Decoene C; Prat A; Jude B
J Thorac Cardiovasc Surg; 2007 Aug; 134(2):424-32. PubMed ID: 17662783
[TBL] [Abstract][Full Text] [Related]
8. Tissue-engineered heart valve leaflets: does cell origin affect outcome?
Shinoka T; Shum-Tim D; Ma PX; Tanel RE; Langer R; Vacanti JP; Mayer JE
Circulation; 1997 Nov; 96(9 Suppl):II-102-7. PubMed ID: 9386083
[TBL] [Abstract][Full Text] [Related]
9. A tissue engineered heart valve implanted in a juvenile sheep model.
Dohmen PM; Ozaki S; Nitsch R; Yperman J; Flameng W; Konertz W
Med Sci Monit; 2003 Apr; 9(4):BR97-BR104. PubMed ID: 12709659
[TBL] [Abstract][Full Text] [Related]
10. Evolution of cell phenotype and extracellular matrix in tissue-engineered heart valves during in-vitro maturation and in-vivo remodeling.
Rabkin E; Hoerstrup SP; Aikawa M; Mayer JE; Schoen FJ
J Heart Valve Dis; 2002 May; 11(3):308-14; discussion 314. PubMed ID: 12056720
[TBL] [Abstract][Full Text] [Related]
11. [Preparation of heart valve scaffold and cell seeding].
Long L; Wu C; Pan L; Qi X; Hong T
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Aug; 21(4):610-3. PubMed ID: 15357443
[TBL] [Abstract][Full Text] [Related]
12. Cholesterol-modified polyurethane valve cusps demonstrate blood outgrowth endothelial cell adhesion post-seeding in vitro and in vivo.
Stachelek SJ; Alferiev I; Connolly JM; Sacks M; Hebbel RP; Bianco R; Levy RJ
Ann Thorac Surg; 2006 Jan; 81(1):47-55. PubMed ID: 16368333
[TBL] [Abstract][Full Text] [Related]
13. From stem cells to viable autologous semilunar heart valve.
Sutherland FW; Perry TE; Yu Y; Sherwood MC; Rabkin E; Masuda Y; Garcia GA; McLellan DL; Engelmayr GC; Sacks MS; Schoen FJ; Mayer JE
Circulation; 2005 May; 111(21):2783-91. PubMed ID: 15927990
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous tissue-engineered pulmonary valved stent implantation.
Lutter G; Metzner A; Jahnke T; Bombien R; Boldt J; Iino K; Cremer J; Stock UA
Ann Thorac Surg; 2010 Jan; 89(1):259-63. PubMed ID: 20103248
[TBL] [Abstract][Full Text] [Related]
15. In vivo remodeling and structural characterization of fibrin-based tissue-engineered heart valves in the adult sheep model.
Flanagan TC; Sachweh JS; Frese J; Schnöring H; Gronloh N; Koch S; Tolba RH; Schmitz-Rode T; Jockenhoevel S
Tissue Eng Part A; 2009 Oct; 15(10):2965-76. PubMed ID: 19320544
[TBL] [Abstract][Full Text] [Related]
16. Time related histopathologic changes of acellularized xenogenic pulmonary valved conduits.
Kim WG; Huh JH
ASAIO J; 2004; 50(6):601-5. PubMed ID: 15672795
[TBL] [Abstract][Full Text] [Related]
17. Construction of autologous human heart valves based on an acellular allograft matrix.
Cebotari S; Mertsching H; Kallenbach K; Kostin S; Repin O; Batrinac A; Kleczka C; Ciubotaru A; Haverich A
Circulation; 2002 Sep; 106(12 Suppl 1):I63-I68. PubMed ID: 12354711
[TBL] [Abstract][Full Text] [Related]
18. Minimally-invasive implantation of living tissue engineered heart valves: a comprehensive approach from autologous vascular cells to stem cells.
Schmidt D; Dijkman PE; Driessen-Mol A; Stenger R; Mariani C; Puolakka A; Rissanen M; Deichmann T; Odermatt B; Weber B; Emmert MY; Zund G; Baaijens FP; Hoerstrup SP
J Am Coll Cardiol; 2010 Aug; 56(6):510-20. PubMed ID: 20670763
[TBL] [Abstract][Full Text] [Related]
19. Tissue engineering of autologous human heart valves using cryopreserved vascular umbilical cord cells.
Sodian R; Lueders C; Kraemer L; Kuebler W; Shakibaei M; Reichart B; Daebritz S; Hetzer R
Ann Thorac Surg; 2006 Jun; 81(6):2207-16. PubMed ID: 16731156
[TBL] [Abstract][Full Text] [Related]
20. Flow-dependent re-endothelialization of tissue-engineered heart valves.
Lichtenberg A; Cebotari S; Tudorache I; Sturz G; Winterhalter M; Hilfiker A; Haverich A
J Heart Valve Dis; 2006 Mar; 15(2):287-93; discussion 293-4. PubMed ID: 16607913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
